Barton, Chris D;
Pizer, Barry;
Jones, Caroline;
Oni, Louise;
Pirmohamed, Munir;
Hawcutt, Daniel B;
(2018)
Identifying cisplatin-induced kidney damage in paediatric oncology patients.
Pediatric Nephrology
, 33
pp. 1467-1474.
10.1007/s00467-017-3765-6.
Preview |
Text
Identifying cisplatin-induced kidney damage in paediatric oncology patients.pdf - Published Version Download (484kB) | Preview |
Abstract
Cisplatin is one chemotherapeutic agent used to treat childhood cancer in numerous treatment protocols, including as a single agent. It is likely to remain in clinical use over the long term. However, cisplatin-related toxicities, including neurotoxicity and nephrotoxicity, are common, affecting treatment, day-to-day life and survival of such children. With one in 700 young adults having survived childhood cancer, patients who have completed chemotherapy that includes cisplatin can experience long-term morbidity due to treatment-related adverse reactions. A better understanding of these toxicities is essential to facilitate prevention, surveillance and management. This review article discusses the effect of cisplatin-induced nephrotoxicity (Cis-N) in children and considers the underlying mechanisms. We focus on clinical features and identification of Cis-N (e.g. investigations and biomarkers) and the importance of magnesium homeostasis and supplementation.
Type: | Article |
---|---|
Title: | Identifying cisplatin-induced kidney damage in paediatric oncology patients |
Location: | Germany |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.1007/s00467-017-3765-6 |
Publisher version: | https://doi.org/10.1007/s00467-017-3765-6 |
Language: | English |
Additional information: | © The Author(s), 2025. This is an Open Access article distributed under the terms of the Creative Commons Attribution Licence (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. https://creativecommons.org/licenses/by/4.0/ |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Renal Medicine |
URI: | https://discovery.ucl.ac.uk/id/eprint/10212658 |
Archive Staff Only
![]() |
View Item |